当前位置: X-MOL 学术J. Label. Comp. Radiopharm. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Efficient radiosynthesis and preclinical evaluation of [18 F]FOMPyD as a PET tracer candidate for TrkB/C receptor imaging
Journal of Labelled Compounds and Radiopharmaceuticals ( IF 1.8 ) Pub Date : 2020-01-29 , DOI: 10.1002/jlcr.3827
Thomas A Singleton 1 , Hussein Bdair 1, 2 , Justin J Bailey 3 , Sangho Choi 3 , Arturo Aliaga 4 , Pedro Rosa-Neto 1, 2, 4 , Ralf Schirrmacher 3 , Vadim Bernard-Gauthier 3 , Alexey Kostikov 1, 2
Affiliation  

Herein we report an efficient radiolabeling of a 18 F-fluorinated derivative of dual inhibitor GW2580, with its subsequent evaluation as a positron emission tomography (PET) tracer candidate for imaging of two neuroreceptor targets implicated in the pathophysiology of neurodegeneration: tropomyosin receptor kinases (TrkB/C) and colony stimulating factor receptor (CSF-1R). [18 F]FOMPyD was synthesized from a boronic acid pinacolate precursor via copper-mediated 18 F-fluorination concerted with thermal deprotection of the four Boc groups on a diaminopyrimidine moiety in an 8.7±2.8% radiochemical yield, a radiochemical purity >99% and an effective molar activity of 187±93 GBq/μmol. [18 F]FOMPyD showed moderate brain permeability in wild-type rats (SUVmax = 0.75) and a slow washout rate. The brain uptake was partially reduced (ΔAUC40-90 = 11.6%) by administration of the non-radioactive FOMPyD (up to 30 μg/kg). In autoradiography, [18 F]FOMPyD exhibits ubiquitous distribution in rat and human brain tissues with relatively high non-specific binding revealed by self-blocking experiment. The binding was blocked by TrkB/C inhibitors, but not with a CSF-1R inhibitor, suggesting selective binding to the former receptor. Although an unfavorable pharmacokinetic profile will likely preclude application of [18 F]FOMPyD as a PET tracer for brain imaging, the concomitant one-pot copper-mediated 18 F-fluorination/Boc-deprotection is a practical technique for the automated radiosynthesis of acid-sensitive PET tracers.

中文翻译:

[18 F]FOMPyD 作为 TrkB/C 受体成像的 PET 示踪剂候选物的有效放射合成和临床前评估

在此,我们报告了双重抑制剂 GW2580 的 18 F-氟化衍生物的有效放射性标记,随后将其评估为正电子发射断层扫描 (PET) 示踪剂候选物,用于对涉及神经变性病理生理学的两个神经受体靶标进行成像:原肌球蛋白受体激酶 (TrkB /C) 和集落刺激因子受体 (CSF-1R)。[18 F]FOMPyD 由硼酸频哪酸酯前体通过铜介导的 18 F-氟化与二氨基嘧啶部分上的四个 Boc 基团的热脱保护协同合成,放射化学产率为 8.7±2.8%,放射化学纯度 >99% 和187±93 GBq/μmol 的有效摩尔活性。[18 F]FOMPyD 在野生型大鼠中表现出中等的脑渗透性 (SUVmax = 0.75) 和缓慢的清除率。大脑摄取部分减少(ΔAUC40-90 = 11。6%)通过施用非放射性 FOMPyD(高达 30 μg/kg)。在放射自显影中,[ 18 F] FOMPyD 在大鼠和人脑组织中普遍分布,自阻断实验显示具有相对较高的非特异性结合。这种结合被 TrkB/C 抑制剂阻断,但不被 CSF-1R 抑制剂阻断,表明与前一种受体的选择性结合。虽然不利的药代动力学特征可能会排除 [18 F]FOMPyD 作为脑成像 PET 示踪剂的应用,但伴随的单锅铜介导的 18 F-氟化/Boc-脱保护是一种用于酸的自动放射合成的实用技术-敏感的 PET 示踪剂。[18 F] FOMPyD 在大鼠和人脑组织中普遍分布,自阻断实验显示具有相对较高的非特异性结合。这种结合被 TrkB/C 抑制剂阻断,但不被 CSF-1R 抑制剂阻断,表明与前一种受体的选择性结合。虽然不利的药代动力学特征可能会排除 [18 F]FOMPyD 作为脑成像 PET 示踪剂的应用,但伴随的单锅铜介导的 18 F-氟化/Boc-脱保护是一种用于酸的自动放射合成的实用技术-敏感的 PET 示踪剂。[18 F] FOMPyD 在大鼠和人脑组织中普遍分布,自阻断实验显示具有相对较高的非特异性结合。这种结合被 TrkB/C 抑制剂阻断,但不被 CSF-1R 抑制剂阻断,表明与前一种受体的选择性结合。虽然不利的药代动力学特征可能会排除 [18 F]FOMPyD 作为脑成像 PET 示踪剂的应用,但伴随的单锅铜介导的 18 F-氟化/Boc-脱保护是一种用于酸的自动放射合成的实用技术-敏感的 PET 示踪剂。
更新日期:2020-01-29
down
wechat
bug